Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
2.32M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
4.73M
-
Shares change
-
+1.31M
-
Total reported value, excl. options
-
$48.5M
-
Value change
-
+$13.4M
-
Number of buys
-
17
-
Number of sells
-
-7
-
Price
-
$10.26
Significant Holders of Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) as of Q2 2023
35 filings reported holding BLAC - Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share as of Q2 2023.
Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.73M shares
.
Largest 10 shareholders include Polar Asset Management Partners Inc. (360K shares), BOOTHBAY FUND MANAGEMENT, LLC (311K shares), ATW SPAC MANAGEMENT LLC (311K shares), GLAZER CAPITAL, LLC (253K shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (250K shares), Saba Capital Management, L.P. (250K shares), Shaolin Capital Management LLC (250K shares), KIM, LLC (228K shares), TWO SIGMA INVESTMENTS, LP (200K shares), and Exos TFP Holdings LLC (200K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.